Cargando…

Identification of circular RNA biomarkers for Pien Tze Huang treatment of CCl(4)-induced liver fibrosis using RNA-sequencing

Pien Tze Huang (PZH), a common hepatoprotective Traditional Chinese Medicine that has been found to be an effective treatment for carbon tetrachloride-induced hepatic damage, including liver fibrosis. Circular RNAs (circRNAs) serve a crucial role in regulating gene expression levels via circRNA/micr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ting, Zhu, Jinhang, Gao, Longhui, Wei, Muyun, Zhang, Di, Chen, Luan, Wu, Hao, Ma, Jingsong, Li, Lixing, Zhang, Na, Wang, Yanjing, Xing, Qinghe, He, Lin, Hong, Fei, Qin, Shengying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437966/
https://www.ncbi.nlm.nih.gov/pubmed/36004475
http://dx.doi.org/10.3892/mmr.2022.12825
_version_ 1784781727289311232
author Wang, Ting
Zhu, Jinhang
Gao, Longhui
Wei, Muyun
Zhang, Di
Chen, Luan
Wu, Hao
Ma, Jingsong
Li, Lixing
Zhang, Na
Wang, Yanjing
Xing, Qinghe
He, Lin
Hong, Fei
Qin, Shengying
author_facet Wang, Ting
Zhu, Jinhang
Gao, Longhui
Wei, Muyun
Zhang, Di
Chen, Luan
Wu, Hao
Ma, Jingsong
Li, Lixing
Zhang, Na
Wang, Yanjing
Xing, Qinghe
He, Lin
Hong, Fei
Qin, Shengying
author_sort Wang, Ting
collection PubMed
description Pien Tze Huang (PZH), a common hepatoprotective Traditional Chinese Medicine that has been found to be an effective treatment for carbon tetrachloride-induced hepatic damage, including liver fibrosis. Circular RNAs (circRNAs) serve a crucial role in regulating gene expression levels via circRNA/micro (mi)RNA/mRNA networks in several human diseases and biological processes. However, whether circRNAs are involved in the underlying mechanism of the therapeutic effects of PZH on liver fibrosis remains unclear. Therefore, the aim of the present study was to investigate these effects using circRNA expression profiles from PZH-treated fibrotic livers in model mice. A case-control study on >59,476 circRNAs from CCl(4)-induced (control group, n=6) and PZH-treated (case group, n=6) mice was performed using circRNA sequencing in liver tissues. PZH treatment resulted in the differential expression of 91 circRNAs, including 58 upregulated and 33 downregulated circRNAs. Furthermore, the construction of competing endogenous networks also indicated that differentially expressed circRNAs acted as miRNA sponges. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis of miRNA targets demonstrated that PZH-affected circRNAs were mainly involved in biological processes such as ‘positive regulation of fibroblast proliferation’, ‘cellular response to interleukin-1’ and ‘regulation of DNA-templated transcription in response to stress’ and in a number of important pathways, such as ‘TNF signaling pathway’, ‘PI3K-Akt signaling pathway’, ‘IL-17 signaling pathway’ and ‘MAPK signaling pathway’. To further validate the bioinformatics data, reverse transcription–quantitative PCR was performed on seven miRNA targets in a human hepatic stellate LX-2 cell model. The results suggested that seven of the miRNAs exhibited regulatory patterns that were consistent with those of the transcriptome sequencing results. Kaplan-Meier survival analysis demonstrated that the expression levels of dihydrodiol dehydrogenase and solute carrier family 7, member 11 gene were significantly associated with patient survival, 269 patients with liver hepatocellular carcinoma from The Cancer Genome Atlas database. To the best of our knowledge, this was the first study to provide evidence that PZH affects circRNA expression levels, which may serve important roles in PZH-treated fibrotic liver through the regulation of functional gene expression. In conclusion, the present study provided new insights into the mechanism underlying the pathogenesis of liver fibrosis and identified potential novel, efficient, therapeutic targets against liver injury.
format Online
Article
Text
id pubmed-9437966
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-94379662022-09-15 Identification of circular RNA biomarkers for Pien Tze Huang treatment of CCl(4)-induced liver fibrosis using RNA-sequencing Wang, Ting Zhu, Jinhang Gao, Longhui Wei, Muyun Zhang, Di Chen, Luan Wu, Hao Ma, Jingsong Li, Lixing Zhang, Na Wang, Yanjing Xing, Qinghe He, Lin Hong, Fei Qin, Shengying Mol Med Rep Articles Pien Tze Huang (PZH), a common hepatoprotective Traditional Chinese Medicine that has been found to be an effective treatment for carbon tetrachloride-induced hepatic damage, including liver fibrosis. Circular RNAs (circRNAs) serve a crucial role in regulating gene expression levels via circRNA/micro (mi)RNA/mRNA networks in several human diseases and biological processes. However, whether circRNAs are involved in the underlying mechanism of the therapeutic effects of PZH on liver fibrosis remains unclear. Therefore, the aim of the present study was to investigate these effects using circRNA expression profiles from PZH-treated fibrotic livers in model mice. A case-control study on >59,476 circRNAs from CCl(4)-induced (control group, n=6) and PZH-treated (case group, n=6) mice was performed using circRNA sequencing in liver tissues. PZH treatment resulted in the differential expression of 91 circRNAs, including 58 upregulated and 33 downregulated circRNAs. Furthermore, the construction of competing endogenous networks also indicated that differentially expressed circRNAs acted as miRNA sponges. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis of miRNA targets demonstrated that PZH-affected circRNAs were mainly involved in biological processes such as ‘positive regulation of fibroblast proliferation’, ‘cellular response to interleukin-1’ and ‘regulation of DNA-templated transcription in response to stress’ and in a number of important pathways, such as ‘TNF signaling pathway’, ‘PI3K-Akt signaling pathway’, ‘IL-17 signaling pathway’ and ‘MAPK signaling pathway’. To further validate the bioinformatics data, reverse transcription–quantitative PCR was performed on seven miRNA targets in a human hepatic stellate LX-2 cell model. The results suggested that seven of the miRNAs exhibited regulatory patterns that were consistent with those of the transcriptome sequencing results. Kaplan-Meier survival analysis demonstrated that the expression levels of dihydrodiol dehydrogenase and solute carrier family 7, member 11 gene were significantly associated with patient survival, 269 patients with liver hepatocellular carcinoma from The Cancer Genome Atlas database. To the best of our knowledge, this was the first study to provide evidence that PZH affects circRNA expression levels, which may serve important roles in PZH-treated fibrotic liver through the regulation of functional gene expression. In conclusion, the present study provided new insights into the mechanism underlying the pathogenesis of liver fibrosis and identified potential novel, efficient, therapeutic targets against liver injury. D.A. Spandidos 2022-08-12 /pmc/articles/PMC9437966/ /pubmed/36004475 http://dx.doi.org/10.3892/mmr.2022.12825 Text en Copyright: © Wang et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Wang, Ting
Zhu, Jinhang
Gao, Longhui
Wei, Muyun
Zhang, Di
Chen, Luan
Wu, Hao
Ma, Jingsong
Li, Lixing
Zhang, Na
Wang, Yanjing
Xing, Qinghe
He, Lin
Hong, Fei
Qin, Shengying
Identification of circular RNA biomarkers for Pien Tze Huang treatment of CCl(4)-induced liver fibrosis using RNA-sequencing
title Identification of circular RNA biomarkers for Pien Tze Huang treatment of CCl(4)-induced liver fibrosis using RNA-sequencing
title_full Identification of circular RNA biomarkers for Pien Tze Huang treatment of CCl(4)-induced liver fibrosis using RNA-sequencing
title_fullStr Identification of circular RNA biomarkers for Pien Tze Huang treatment of CCl(4)-induced liver fibrosis using RNA-sequencing
title_full_unstemmed Identification of circular RNA biomarkers for Pien Tze Huang treatment of CCl(4)-induced liver fibrosis using RNA-sequencing
title_short Identification of circular RNA biomarkers for Pien Tze Huang treatment of CCl(4)-induced liver fibrosis using RNA-sequencing
title_sort identification of circular rna biomarkers for pien tze huang treatment of ccl(4)-induced liver fibrosis using rna-sequencing
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437966/
https://www.ncbi.nlm.nih.gov/pubmed/36004475
http://dx.doi.org/10.3892/mmr.2022.12825
work_keys_str_mv AT wangting identificationofcircularrnabiomarkersforpientzehuangtreatmentofccl4inducedliverfibrosisusingrnasequencing
AT zhujinhang identificationofcircularrnabiomarkersforpientzehuangtreatmentofccl4inducedliverfibrosisusingrnasequencing
AT gaolonghui identificationofcircularrnabiomarkersforpientzehuangtreatmentofccl4inducedliverfibrosisusingrnasequencing
AT weimuyun identificationofcircularrnabiomarkersforpientzehuangtreatmentofccl4inducedliverfibrosisusingrnasequencing
AT zhangdi identificationofcircularrnabiomarkersforpientzehuangtreatmentofccl4inducedliverfibrosisusingrnasequencing
AT chenluan identificationofcircularrnabiomarkersforpientzehuangtreatmentofccl4inducedliverfibrosisusingrnasequencing
AT wuhao identificationofcircularrnabiomarkersforpientzehuangtreatmentofccl4inducedliverfibrosisusingrnasequencing
AT majingsong identificationofcircularrnabiomarkersforpientzehuangtreatmentofccl4inducedliverfibrosisusingrnasequencing
AT lilixing identificationofcircularrnabiomarkersforpientzehuangtreatmentofccl4inducedliverfibrosisusingrnasequencing
AT zhangna identificationofcircularrnabiomarkersforpientzehuangtreatmentofccl4inducedliverfibrosisusingrnasequencing
AT wangyanjing identificationofcircularrnabiomarkersforpientzehuangtreatmentofccl4inducedliverfibrosisusingrnasequencing
AT xingqinghe identificationofcircularrnabiomarkersforpientzehuangtreatmentofccl4inducedliverfibrosisusingrnasequencing
AT helin identificationofcircularrnabiomarkersforpientzehuangtreatmentofccl4inducedliverfibrosisusingrnasequencing
AT hongfei identificationofcircularrnabiomarkersforpientzehuangtreatmentofccl4inducedliverfibrosisusingrnasequencing
AT qinshengying identificationofcircularrnabiomarkersforpientzehuangtreatmentofccl4inducedliverfibrosisusingrnasequencing